Information:
Error:
ID
30895
Description
Study part: Pharmacodynamics urine- 1-dehydrothromboxane B2 (PDU), day 1. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Keywords
Versions (1)
- 7/2/18 7/2/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 2, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Pharmacodynamics urine- 1-dehydrothromboxane B2 (PDU) day 1 Pazopanib Macular Degeneration MD1103367
Pharmacodynamics urine- 1-dehydrothromboxane B2 (PDU) day 1
- StudyEvent: ODM
Similar models
Pharmacodynamics urine- 1-dehydrothromboxane B2 (PDU) day 1
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
PHARMACODYNAMICS URINE -11-dehydrothromboxane B2 (PDU) Pre-treatment
C0851347 (UMLS CUI-1)
C0042036 (UMLS CUI-2)
C2709094 (UMLS CUI-4)
C0042036 (UMLS CUI-2)
C2709094 (UMLS CUI-4)
Date and time of sample
Item
Date/time of sample
datetime
C0011008 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,3])
Sample lD
Item
Sample lD
text
C1299222 (UMLS CUI [1])